Duvakitug is a monoclonal antibody commercialized by Sanofi, with a leading Phase II program in Ulcerative Colitis;Crohn's Disease (Regional Enteritis).

APSA-02 is a biologic commercialized by Armata Pharmaceuticals, with a leading Phase II program in Bacteremia.

Researchers have found that the soil we walk on is far more than just dirt; it may be harboring tiny genetic codes that ...

Bedaquiline, originally approved for drug-resistant tuberculosis, is an innovative agent that inhibits the bacterial energy ...

Our gut microbiome, home to trillions of beneficial bacteria, plays a critical role in immunity, inflammation control, and ...

However, the authors are already planning to expand it to other bacterial species with a high potential for the production of ...

However, the authors are already planning to expand it to other bacterial species with a high potential for the production of unknown natural products. Beyond this, ACTIMOT holds potential for ...

Analysis - Infectious or chronic diseases such as long COVID, Alzheimer's disease and traumatic brain injury can cause inflammation in the brain, or neuroinflammation, that weakens muscles. While ...

Microorganisms produce a wide variety of natural products that can be used as active ingredients to treat diseases such as ...

The trillions of microbial cells in our gastrointestinal tract have their own genomes and metabolic products, many of which ...

M icrobiologists have studied bacterial defense mechanisms against phages for decades. But until less than a decade ago, ...